Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model

Infection and Immunity

Volumn 64, Issue 4, 1996, Pages 1140-1145

  Sato, Katsuro ^a   Quartey, Moses K ^a   Liebeler, Carol L ^a   Le, Chap T ^a,b   Giebink, G Scott ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLYSIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PNEUMOLYSIN; PROCAINE PENICILLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINCHILLA; CONTROLLED STUDY; GROWTH RATE; INCUBATION TIME; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0029959030     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.4.1140-1145.1996     Document Type: Article

References (43)

1. Alexander, J. E., R. A. Lock, C. C. A. M. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994 Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62:5683-5688.
2. Berry, A. M., J. C. Paton, and D. Hansman. 1992. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microb, Pathog.,12:87-93.
3. Berry, A. M., J. Vother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun 57:2037-2042.
4. Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media. Pediatr. Infect. Dis J. 11:S7-S11.
5. Canafax, D. M., N. Nonomura, G. R. Erdman, C. T. Le, S. K. Juhn, and G. S. Giebink. 1989. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharm. Res. 6:279-285.
6. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton, G. J. Boulnois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Infect Dis 172:119-123
7. Carlsen, B. D., M. Kawana, C. Kawana, A. Tomasz, and G. S. Giebink. 1992 Role of bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae. Infect. Immun. 60:2850-2854.
8. Feldman, C., N. C. Munro, P. K. Jeffery, T. J. Mitchell, P. W, Andrew, G. J. Boulnois, D. Guerreiro, J. A. L. Rohde, H. C. Todd, P. J. Cole, and R. Wilson. 1991. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo Am. J. Respir. Cell Mol. Biol. 5:416-423.
9. Friedland, I. R., M. M. Paris, S. Hickey, S. Shelton, K. Olsen, J. C. Paton, and G. H. McCracken. 1995. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J. Infect Dis 172:805-809.
10. Giebink, G. S. 1989. The microbiology of otitis media. Pediatr. Infect. Dis. J. 8:S18-S20.
11. Giebink, G. S., I. K. Berzins, and P. G. Quie. 1980. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Ann. Otol. Rhinol. Larynsol. 68(Suppl.):339-343.
12. Giebink, G. S., S. K. Juhn, M. L. Weber, and C. T. Le. 1982. The bacteriology and cytology of chronic otitis media with effusion. Pediatr. Infect. Dis. 1: 98-103.
13. Himi, T., T. Suzuki, H. Kodama, H. Takezawa, and A. Kataura. 1992. Immunologic characteristics of cytokines in otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 101:21-25.
14. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1β by human mononuclear phagocytes. Infect. Immun. 62:1501-1503.
15. Johnson, M. D., J. E. Fitzgerald, G. Leonard, J. A. Burleson, and D. L. Kreutzer. 1994. Cytokines in experimental otitis media with effusion. Laryngoscope 104:191-196.
16. Johnson, M. K., D. Boese-Marrazzo, and W. A. Pierce, Jr. 1981 Effects of pneumolysin on human polymorphonuclear leukocytes and platelets Infect. Immun. 34:171-176.
17. Johnson, M. K., J. A. Hobden, R. J. O'Callaghan, and J. M. Hill. 1992. Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr. Eye Res 11:1221-1225.
18. Juhn, S. K., W. J. Garvis, C. J. Lees, C. T. Le, and C. S. Kim. 1994 Determining otitis media severity from middle ear fluid analysis. Ann. Otol. Rhinol Laryngol. 103:43-45.
19. Kawana, M., C. Kawana, and G. S. Giebink. 1992. Penicillin treatment accelerates middle ear inflammation in experimental otitis media. Infect. Immun 60:1908-1912.
20. Lee. C. J., R. A. Lock, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide-pneumolysoid conjugate. Vaccine 12:875-878.
21. Leinonen, M. K. 1980. Detection of pneumococcal capsular polysaccharide antigens by latex agglutination, counterimmunoelectrophoresis, and radioimmunoassay in middle ear exudates in acute otitis media J. Clin Microbiol. 11:135-140
22. Lock, R. A., D. Hansman, and J. C. Paton. 1992. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae Microb. Pathog. 12:137-143.
23. Maxwell, K. S., J. E. Fitzgerald, J. A. Burleson, G. Leonard, R. Carpenter, and D. L. Kreutzer. 1994. Interleukin-8 expression in otitis media Laryngoscope 104:989-995.
24. Moreillon, P., Z. Markiewicz, S. Nachman, and A. Tomasz. 1990. Two bactericidal targets for penicillin in pneumococci autolysis-dependent and autolysis-independent killing mechanisms. Antimicrob. Agents Chemother. 34:33-39.
25. Nonomura, N., G. S. Giebink, S. K. Juhn, T. Harada, and D. Aeppli. 1991. Pathophysiology of Streptococcus pneumoniae otitis media: kinetics of the middle ear biochemical and cytological host responses. Ann. Otol. Rhinol Laryngol. 100:236-243.
26. Nonomura, N., G. S. Giebink, D. Zelterman, T. Harada, and S. K. Juhn. 1991 Middle ear fluid lysozyme source in experimental otitis media Ann. Otol. Rhinol. Laryngol. 100:593-596
27. Paton, J. C., and A. Ferrante. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41:1212-1216.
28. Paton, J. C., R. A. Lock, and D. J. Hansman. 1983. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect. Immun. 40:548-552.
29. Rampart, M., A. G. Herman, B. Grillet, G. Opdenakker, and J. Van Damme. 1992 Development and application of a radioimmunoassay for interleukin-8. detection of interleukin-8 in synovial fluids from patients with inflam-matory joint disease. Lab. Invest 66:512-518
30. Rayner, C. F. J., A. D. Jackson, A. Rutman, A. Dewar, T. J. Mitchell, P. W. Andrew, P. J. Cole, and R. Wilson. 1995. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect. Immun 63:442-447.
31. Ripley-Petzoldt, M. L., G. S. Giebink, S. K. John, D. Aeppli, A. Tomasz, and E. Tuomanen. 1988. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J. Infect. Dis. 157:245-255
32. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pncumococcal pneumonia. J Clin. Invest. 95:142-150.
33. Sanchez-Puelles, J. M., C. Ronda, J. L. Garcia, P. Garcia, R, Lopez, and E. Garcia. 1986. Searching for autolysin functions. Characterization of pneumococcal mutant deleted in the lyt A gene. Eur. J. Biochem. 158:289-293.
34. Sato, K., M. K. Quartey, C. L. Liebeler, and G. S. Giebink. 1995. Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation. Antirmicrob. Agents Chemother 39:1896-1898
35. 34a.Sato, K., M. K. Quartey, C. L. Liebeler, C. T. Le, and G. S. Giebink. Unpublished data.
36. Takeuchi, K., K. Maesato, A. Yuta, and Y. Sakakura. 1994. Interleukin-8 gene expression in middle ear effusions. Ann. Otol. Rhinol. Laryngol. 103: 404-107
37. Tuomanen, E., B. Hengstler, R. Rick, M. A. Bray, O. Zak, and A. Tomasz, 1987 Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J. Infect. Dis. 155:985-990
38. Tuomanen, E., H. Liu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis 151:859-868.
39. Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect Dis. 151:535-540.
40. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83:9679-9683.
41. Virolainen, A., P. Salo, J. Jero, P. Karma, J. Eskola, and M. Leinonen. 1994. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media J Clin Microbiol 32:2667-2670.
42. Yellon, R. F., G. Leonard, P. T. Marucha, R. Craven, R, J. Carpenter, W. B. Lehmann, J. A. Burleson, and D. L. Kreutzer. 1991. Characterization of cytokines present in middle ear effusions. Laryngoscope 101:165-169.
43. Yellon, R. F., G. Leonard, P. Marucha, J. Sidman, R. Carpenter, J. Burleson, J, Carlson, and D. Kreutzer. 1992. Demonstration of interleukin 6 in middle ear effusions. Arch. Otolaryngol. Head Neck Surg 118:745-748